168 related articles for article (PubMed ID: 30208145)
1. Oral omega 3 in different proportions of EPA, DHA, and antioxidants as adjuvant in treatment of keratoconjunctivitis sicca in dogs.
Silva DA; Nai GA; Giuffrida R; Sgrignoli MR; Santos DRD; Donadão IV; Nascimento FF; Dinallo HR; Andrade SF
Arq Bras Oftalmol; 2018; 81(5):421-428. PubMed ID: 30208145
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the efficacy of 0.03% tacrolimus eye drops diluted in olive oil and linseed oil for the treatment of keratoconjunctivitis sicca in dogs.
Zulim LFDC; Nai GA; Giuffrida R; Pereira CSG; Benguella H; Cruz AG; Foglia BTD; Batista ADS; Andrade SF
Arq Bras Oftalmol; 2018; 81(4):293-301. PubMed ID: 29995121
[TBL] [Abstract][Full Text] [Related]
3. Effect of topical 0.02% tacrolimus aqueous suspension on tear production in dogs with keratoconjunctivitis sicca.
Berdoulay A; English RV; Nadelstein B
Vet Ophthalmol; 2005; 8(4):225-32. PubMed ID: 16008701
[TBL] [Abstract][Full Text] [Related]
4. Assessment of corneal and conjunctival metaplasia by impression cytology during the treatment of canine keratoconjunctivitis sicca.
Radziejewski K; Balicki I; Szadkowski M
Acta Vet Hung; 2018 Jun; 66(2):189-203. PubMed ID: 29958527
[TBL] [Abstract][Full Text] [Related]
5. Comparative clinical evaluation of tacrolimus and cyclosporine eye drops for the treatment of canine keratoconjunctivitis sicca.
Radziejewski K; Balicki I
Acta Vet Hung; 2016 Sep; 64(3):313-329. PubMed ID: 27653428
[TBL] [Abstract][Full Text] [Related]
6. Clinical evaluation of pimecrolimus eye drops for treatment of canine keratoconjunctivitis sicca: a comparison with cyclosporine A.
Ofri R; Lambrou GN; Allgoewer I; Graenitz U; Pena TM; Spiess BM; Latour E
Vet J; 2009 Jan; 179(1):70-7. PubMed ID: 17950639
[TBL] [Abstract][Full Text] [Related]
7. Comparative efficacy of topical oclacitinib 0.1% and tacrolimus 0.01% in canine keratoconjunctivitis sicca.
de Oliveira JK; Williams DL; Bollmann C; de Seabra NM; Bortolini M; Montiani-Ferreira F
Vet Ophthalmol; 2019 Sep; 22(5):633-643. PubMed ID: 30724448
[TBL] [Abstract][Full Text] [Related]
8. The effect of topical pimecrolimus on keratoconjunctivitis sicca and chronic superficial keratitis in dogs: results from an exploratory study.
Nell B; Walde I; Billich A; Vit P; Meingassner JG
Vet Ophthalmol; 2005; 8(1):39-46. PubMed ID: 15644099
[TBL] [Abstract][Full Text] [Related]
9. Clinical and light microscopic studies of the conjunctival tissues of dogs with bilateral keratoconjunctivitis sicca before and after treatment with topical 2% cyclosporine.
Izci C; Celik I; Alkan F; Erol M; Sur E
Biotech Histochem; 2015 Apr; 90(3):223-30. PubMed ID: 25747049
[TBL] [Abstract][Full Text] [Related]
10. Clinical evaluation of 1% cyclosporine for topical treatment of keratoconjunctivitis sicca in dogs.
Olivero DK; Davidson MG; English RV; Nasisse MP; Jamieson VE; Gerig TM
J Am Vet Med Assoc; 1991 Oct; 199(8):1039-42. PubMed ID: 1748606
[TBL] [Abstract][Full Text] [Related]
11. Comparison of topical 0.03% tacrolimus and homologous injectable platelet-rich plasma in the treatment of keratoconjunctivitis sicca in dogs.
Estanho GJG; Passareli JVGC; Pando LDS; Vieira DE; Nai GA; Santarém CL; Andrade SF
Vet World; 2023 Jan; 16(1):134-143. PubMed ID: 36855346
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of topical nerve growth factor treatment in dogs affected by dry eye.
Coassin M; Lambiase A; Costa N; De Gregorio A; Sgrulletta R; Sacchetti M; Aloe L; Bonini S
Graefes Arch Clin Exp Ophthalmol; 2005 Feb; 243(2):151-5. PubMed ID: 15650854
[TBL] [Abstract][Full Text] [Related]
13. Topical administration of cyclosporine for treatment of keratoconjunctivitis sicca in dogs.
Morgan RV; Abrams KL
J Am Vet Med Assoc; 1991 Oct; 199(8):1043-6. PubMed ID: 1748607
[TBL] [Abstract][Full Text] [Related]
14. The Effect of Periocular Fatty Acids and 0.15% Hyaluronate Eye Drops Application on Keratoconjunctivitis Sicca in Dogs: An Exploratory Study.
Amalfitano C; Pasolini MP; Nieddu A; Della Valle G; Fiorentin PG; Lamagna F; Lamagna B
Top Companion Anim Med; 2019 Jun; 35():18-25. PubMed ID: 31122683
[TBL] [Abstract][Full Text] [Related]
15. The role of apoptosis in the pathogenesis of canine keratoconjunctivitis sicca: the effect of topical Cyclosporin A therapy.
Gao J; Schwalb TA; Addeo JV; Ghosn CR; Stern ME
Cornea; 1998 Nov; 17(6):654-63. PubMed ID: 9820947
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of adjunctive therapy using Vizoovet in improving clinical signs of keratoconjunctivitis sicca in dogs: A pilot study.
Dees DD; Kent MS
Vet Ophthalmol; 2020 Jul; 23(4):632-639. PubMed ID: 32386123
[TBL] [Abstract][Full Text] [Related]
17. Conjunctival impression cytology from dogs with keratoconjunctivitis sicca. Pre- and post-treatment with topical cyclosporine.
Bounous DI; Krenzer KL; Kaswan RL; Hirsh SG
Adv Exp Med Biol; 1998; 438():997-1000. PubMed ID: 9635001
[No Abstract] [Full Text] [Related]
18. The effects of topical aqueous sirolimus on tear production in normal dogs and dogs with refractory dry eye.
Spatola R; Nadelstein B; Berdoulay A; English RV
Vet Ophthalmol; 2018 May; 21(3):255-263. PubMed ID: 28972684
[TBL] [Abstract][Full Text] [Related]
19. Histologic characteristics and local cellular immunity of the gland of the third eyelid after topical ophthalmic administration of 2% cyclosporine for treatment of dogs with keratoconjunctivitis sicca.
Izci C; Celik I; Alkan F; Ogurtan Z; Ceylan C; Sur E; Ozkan Y
Am J Vet Res; 2002 May; 63(5):688-94. PubMed ID: 12013470
[TBL] [Abstract][Full Text] [Related]
20. Effect of once daily topical 0.3% naltrexone on tear parameters and corneal sensitivity in dogs with uncontrolled keratoconjunctivitis sicca: a double-masked randomized placebo-controlled clinical trial.
Chen T; Powell CC
Vet Ophthalmol; 2015 Nov; 18(6):497-501. PubMed ID: 25675975
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
